Home › NDC Lookup › Ingredients › Venlafaxine Hydrochloride › 65841-0753-06
venlafaxine hydrochloride 150 mg Capsule, Extended Release, 30-count — NDC 65841-0753-06 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

venlafaxine hydrochloride 150 mg Capsule, Extended Release, 30-count — NDC 65841-753-06 (Billing 65841-0753-06)

by Zydus Lifesciences Limited · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

This is a package of 30 capsules of venlafaxine hydrochloride 150 mg Capsule, Extended Release from Zydus Lifesciences Limited, marketed since Jun 2011 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 65841-0753-06
🏷️ FDA NDC (as labeled) 65841-753-06 billing pads the product segment with a zero
This package
Contains30-count Pack sizes3 compare ↓
Also priced by: Part D plans $0.2146/unit — full pricing hub ↓
Main listing for product 65841-753 · Also comes in: 90 capsules 65841-753-16 1000 capsules 65841-753-10
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65841-753-06
Product NDC 65841-753
11-digit billing NDC 65841075306
RxCUI 313581, 313583, 313585
UNII 7D7RX5A8MO
UPC 0365841752106, 0365841753103
Application # ANDA090174
SPL Set ID 1be1be3a-304b-4e31-8732-335247029191
Established class (EPC) Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2011-06-01
Route ORAL
Dosage form CAPSULE, EXTENDED RELEASE
Substance VENLAFAXINE HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS
Quick answers
  • RxCUI (RxNorm): 313581
Why two NDCs? The FDA registers this code as 65841-753-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65841-0753-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Serotonin and Norepinephrine Reuptake Inhibitor class.

Pharmacologic class Serotonin and Norepinephrine Reuptake Inhibitor
Drug family (ATC) Other antidepressants
How it works Norepinephrine Uptake Inhibitors, Serotonin Uptake Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats major depressive disorder. Depending on the product, it is also used for social anxiety disorder, generalized anxiety disorder and panic disorder. Your pharmacist can con...
  • Take extended-release forms once a day with food, at about the same time each day. Swallow tablets and capsules whole. A capsule can be opened onto applesauce if swallowing is hard...
  • Nausea, sleepiness, dry mouth, sweating, constipation and loss of appetite are common. Some people have sexual side effects. Call your doctor if side effects are severe or don’t ea...
  • Please don’t stop suddenly. Stopping or cutting the dose quickly can cause dizziness, nausea, anxiety, insomnia and electric-shock feelings. Your prescriber will lower the dose gra...
📖 Read our full Venlafaxine guide →
1
Nutrient depletion considerations

Venlafaxine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.2146 $6.44 / 30 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
65841-0753-06 You're viewing this Main listing 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE 2011-06-01 — Active
65841-0753-10 65841-753-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE 2011-06-01 — Active
65841-0753-16 65841-753-16 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE 2011-06-01 — Active

You're viewing the smallest of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 30-count package — 30 capsule, extended release in 1 bottle.
How does this package differ from NDC 65841-0753-16?
Both are venlafaxine hydrochloride 150 mg Capsule, Extended Release — the drug itself is identical. This page's package is the 30-count one, while NDC 65841-0753-16 is the 90 capsules package.
What NDC number is used to bill for this package of venlafaxine hydrochloride 150 mg Capsule, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Venlafaxine Hydrochloride 150 mg 00093-7386-05 Teva 500 capsules $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 00904-7489-61 Major 1 capsule $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 42806-0603-05 Epic 500 capsules $0.116 AB Availability likely —
venlafaxine hydrochloride 150 mg 43598-0002-05 Dr.Reddys 500 capsules $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 50268-0875-15 AvPAK 1 capsule $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 65862-0697-01 Aurobindo 100 capsules $0.116 — Availability likely —
Venlafaxine Hydrochloride 150 mg 68084-0713-01 American 1 capsule $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 70010-0186-03 Granules 30 capsules $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 70710-1700-00 Zydus 1000 capsules $0.116 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 82009-0058-05 QUALLENT 500 capsules $0.116 AB Availability likely —
Venlafaxine hydrochloride 150 mg 33342-0196-07 Macleods 30 capsules $0.139 AB FDA listed —
Effexor XR 150 mg 00008-0836-21 Wyeth 30 capsules $21.625 AB Discontinued —
Effexor XR 150 mg 58151-0127-77 Viatris 90 capsules $21.625 AB Availability likely —
Venlafaxine Hydrochloride 150 mg 00615-8510-39 NCS 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 10135-0827-10 Marlex 1000 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 31722-0004-01 Camber 10 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 42291-0899-30 AvKARE 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 46708-0794-30 Alembic 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-2519-00 A-S 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-5890-00 A-S 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-6896-00 A-S 90 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-7323-00 A-S 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-7324-00 A-S 90 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 50090-7942-00 A-S 30 capsules — AB FDA listed —
venlafaxine hydrochloride 150 mg 55111-0455-01 Dr.Reddy's 100 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 62332-0794-30 Alembic 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 63187-0420-30 Proficient 30 capsules — AB FDA listed —
venlafaxine hydrochloride 150 mgthis 65841-0753-06 Zydus 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 67046-1656-03 Coupler 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 68071-3727-09 NuCare 90 capsules — AB FDA listed —
venlafaxine hydrochloride 150 mg 68071-4442-09 NuCare 90 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 68071-5020-09 NuCare 90 capsules — AB FDA listed —
venlafaxine hydrochloride 150 mg 68382-0036-06 Zydus 30 capsules — AB FDA listed —
venlafaxine hydrochloride 150 mg 68788-6806-01 Preferred 100 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 68788-8072-03 Preferred 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 68788-8752-03 Preferred 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 68788-8774-01 Preferred 100 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 70518-2259-00 REMEDYREPACK 90 capsules — AB Discontinued —
Venlafaxine Hydrochloride 150 mg 70518-4154-00 REMEDYREPACK 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 70771-1838-00 Zydus 1000 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 71335-1642-01 Bryant 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 71335-1812-01 Bryant 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 71335-2495-01 Bryant 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 71335-2992-01 Bryant 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 71785-1008-00 Annora 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 72603-0749-01 NorthStar 90 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 72888-0181-30 Advagen 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 76420-0632-01 Asclemed 100 capsules — AB FDA listed —
Venlafaxine HCL ER 150 mg 80425-0194-02 Advanced 60 capsules — AB FDA listed —
Venlafaxine hydrochloride ER 150 mg 80425-0297-01 Advanced 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 82804-0038-30 Proficient 30 capsules — AB FDA listed —
Venlafaxine Hydrochloride 150 mg 24658-0127-05 PURACAP 500 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2011
On the market since
Jun 2011
📍
2026
Currently FDA-listed
15 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Gray / White / Orange
ShapeCapsule
ImprintZA;37;150;mg
Size21 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII P2OM2Q86BI
    A synthetic polymer made from two types of plastic-like chemicals bonded together. It forms a protective coating on tablets or capsules to control how quickly the medicine dissolves and releases in your digestive system.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

11 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA090174 (ANDA)
Labeler code65841
First marketedJun 2011
Product typeHuman Prescription Drug
Portfolio717 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
💬 Medication Guide 2 words ▾

SPL MEDGUIDE

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 90 capsules (65841-0753-16), 1000 capsules (65841-0753-10). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.